Skip to content
  • Friday 9th October 2026
  • Healthier Welfare

    Healthier Welfare

    Nurturing Health and Well-being for All

    • Home
    • Hengrui Pharma

    Tag: Hengrui Pharma

    • Pharma News

    Prostate Cancer Drug Approval: Hengrui Pharma’s New Hope

    Prostate cancer drug approval has been achieved by Hengrui Pharma, promising new treatment options for patients in Europe.

    View the post
    Oliver EdwardsOctober 9, 2026
    Tags: cancer treatmentDrug ApprovalEuropean MarketHengrui PharmaoncologypharmaceuticalsProstate Cancer

    Contact us

    Archives

    • October 2026
    • September 2026
    • November 2025
    • October 2025
    • August 2025
    • July 2025
    • November 2024
    • December 2023
    • March 2023
    • November 2022

    Categories

    • Beauty&Style
    • Dental
    • Diet
    • finance
    • Fitness&Exercise
    • Food&Recipe
    • general news
    • Health
    • Live Gaming
    • Medicalcare
    • pharma
    • Pharma News
    • pharmaceuticals
    • Weightloss
    • Yoga

    Popular News

    • Prostate cancer drug approval
      October 9, 2026Oliver Edwards

      Prostate Cancer Drug Approval: Hengrui Pharma’s New Hope

    • October 5, 2026Oliver Edwards

      Deep Health AI India Secures Smart Debt Acquisition Deal

    • September 30, 2026Oliver Edwards

      Healthcare stocks slide: The Worst Impact on Investors

    • September 28, 2026Oliver Edwards

      Apixaban Oral Suspension: Safe and Proven FDA Approval

    • FDA approval everolimus
      September 23, 2026Oliver Edwards

      FDA Approval Everolimus: Is It the Best Option for Patients?

    Pages

    • About Us
    • Contact Us
    • Write for Us
    • Terms of Use
    • Disclaimer
    • Advertise with Us

    Recent Post

    • Prostate cancer drug approval
      October 9, 2026Oliver Edwards

      Prostate Cancer Drug Approval: Hengrui Pharma’s New Hope

    • October 5, 2026Oliver Edwards

      Deep Health AI India Secures Smart Debt Acquisition Deal

    • September 30, 2026Oliver Edwards

      Healthcare stocks slide: The Worst Impact on Investors

    • September 28, 2026Oliver Edwards

      Apixaban Oral Suspension: Safe and Proven FDA Approval

    • FDA approval everolimus
      September 23, 2026Oliver Edwards

      FDA Approval Everolimus: Is It the Best Option for Patients?

    About Us·Contact Us·Write for Us·Terms of Use·Disclaimer·Advertise with Us

    Tags

    AI banking ANI Pharmaceuticals Apixaban Assam CM banking innovation cancer treatment debt acquisition Deep Health AI Drug Approval drug development drug launch Euro Head Dual Port European Market everolimus FDA approval generic drugs healthcare healthcare access healthcare policy healthcare stocks health technology Hengrui Pharma Himanta Biswa Sarma India India finance investment investor concerns IV fluids Kshitij Polyline Lupin medical supplies medicine prices NPPA oncology oral suspension pharmaceutical pricing pharmaceuticals pharma news phygital banking Prostate Cancer retail vs consumer SC ruling Silica Healthcare stock market tentative approval

    Yoga

    • March 9, 2023March 22, 2023Donald Bell

      The Science of Yoga: How it Affects the Brain and Body

    • March 9, 2023March 22, 2023Donald Bell

      Yoga for Beginners: Tips and Tricks to Get Started

    • March 9, 2023March 22, 2023Donald Bell

      Exploring Different Types of Yoga: Find Your Perfect Practice

    • March 9, 2023March 22, 2023Donald Bell

      The Benefits of Yoga for Mind and Body

    • March 9, 2023March 22, 2023Donald Bell

      Why Yoga is the Perfect Cross-Training Activity for Athletes

    Featured

    Copyright All rights reserved.Theme Bulletin News by Shadow Themes